HEPATITIS B VIRUS INHIBITOR

PROBLEM TO BE SOLVED: To provide a peptide composition which is specific to diagnosis, treatment or prophylaxis of hepatitis B virus infection. SOLUTION: The present invention provides peptides and other molecules, inhibiting assembly of a hepatitis B virus, obtained by selecting peptides which inhi...

Full description

Saved in:
Bibliographic Details
Main Authors DYSON MICHAEL RICHARD, MURRAY KENNETH
Format Patent
LanguageEnglish
Published 29.05.2008
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:PROBLEM TO BE SOLVED: To provide a peptide composition which is specific to diagnosis, treatment or prophylaxis of hepatitis B virus infection. SOLUTION: The present invention provides peptides and other molecules, inhibiting assembly of a hepatitis B virus, obtained by selecting peptides which inhibit the assembly of the hepatitis B virus by binding virus to a core antigen and prevent binding of the core antigen to surface antigen from a fused phage library presented by a fibrous phage, a method for treating them and a pharmaceutical composition comprising them. COPYRIGHT: (C)2008,JPO&INPIT
Bibliography:Application Number: JP20070300663